Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2703 of 6351
-
Can microneedling and UV light restore skin color in vitiligo?
Disease control Not yet recruitingThis study is a randomized controlled trial comparing microneedling with topical minoxidil 5% versus microneedling with minoxidil combined with NB-UVB phototherapy in stable vitiligo. It aims to evaluate both clinical and histopathological outcomes in 30 patients with non-segmen…
Phase 2 • Sponsor: Sohag University • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New device aims to stop leaks after prostate surgery without needles or surgery
Symptom relief By invitation onlyUrinary incontinence is a common complication following prostatectomy and affects a substantial proportion of patients. Despite advances in surgical technique, many patients experience persistent symptoms that negatively impact quality of life. Current management strategies inclu…
Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Could a Weight-Loss drug curb alcohol cravings? new brain study investigates
Knowledge-focused Recruiting nowBackground: Glucagon-like peptide 1 (GLP-1) agonist drugs are used to treat diabetes and aid weight loss. They may also help reduce cravings for drugs and alcohol. Researchers want to know if a GLP-1 drug (tirzepatide) can lessen the urge to drink in people with alcohol use diso…
Phase 1 • Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
New pill aims to shrink spleen and ease symptoms in hard-to-treat bone marrow cancer
Disease control Recruiting nowThis is a phase Ib study evaluating PMD-026, an oral inhibitor of ribosomal protein S6 kinase A1 (RSK1), in participants with myelofibrosis (MF).The dose escalation portion utilizes a standard 3+3 design to evaluate two dose levels with an additional dose de-escalation portion to…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Could a common gout pill boost antidepressants?
Symptom relief Recruiting nowMajor depressive disorder (MDD) is one of the most common psychiatric disorders with serious socioeconomic consequences on daily life and health care costs. Despite the advent of newer antidepressants that target monoamine pathways, nearly 50% of patients have no response to firs…
Phase 2/3 • Sponsor: Tanta University • Aim: Symptom relief
Last updated Aug 20, 2026 00:00 UTC
-
Could a tiny nerve zap ease stubborn knee arthritis pain?
Symptom relief Recruiting nowThis observational cohort study aims to evaluate the clinical effect of adding ultrasound-guided pulsed radiofrequency treatment of the distal superficial and deep sensory branches of the nerve to vastus medialis to conventional genicular nerve radiofrequency treatment in patient…
Sponsor: Diskapi Teaching and Research Hospital • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
New brain zapping technique could ease Parkinson's symptoms without surgery
Symptom relief Recruiting nowTranscranial temporal interference stimulation (tTIS) is a non-invasive deep brain stimulation method. This study aims to comprehensively explore the efficacy and safety of bilateral subthalamic nucleus (STN) tTIS on motor and non-motor symptoms in patients with Parkinson's disea…
Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 13:03 UTC
-
Biofeedback training aims to restore sexual health in cervical cancer survivors
Symptom relief Recruiting nowThis randomized controlled trial aims to evaluate the efficacy of biofeedback-assisted pelvic floor muscle training on radiation-induced sexual dysfunction in cervical cancer survivors following pelvic radiotherapy. Participants will be randomly assigned to receive either biofeed…
Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New heart rehab study tests hybrid approach to boost patient participation
Disease control Recruiting nowCardiac rehabilitation (CR) is an effective evidence-based intervention that improves outcomes in patients with acute coronary syndrome (ACS), but many eligible patients do not complete the program. A hybrid CR intervention that combines telehealth, home-based, and clinic-based c…
Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can warning labels on cannabis products change how consumers think about risk?
Knowledge-focused Recruiting nowThis discrete choice experiment (DCE) study aims to address gaps in cannabis packaging regulatory research by testing how variations in cannabis packaging and health warning design impact reactions to packaging and intentions about cannabis use. The goal of this work is to identi…
Sponsor: University of Oklahoma • Aim: Knowledge-focused
Last updated Jul 29, 2026 00:00 UTC
-
Can a new access tool make polyp removal faster and safer?
Symptom relief Recruiting nowThis prospective, single-center, observational feasibility and safety study will evaluate the use of the GelPOINT® Path transanal access platform during endoscopic submucosal dissection (ESD) for the removal of colorectal polyps. The GelPOINT® Path system is designed to improve a…
Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Could a cream stop scarring hair loss? small trial begins
Disease control Recruiting nowThis study evaluates the safety, tolerability, and biomarker effects of twice-daily topical delgocitinib 2% cream in adults with lichen planopilaris (LPP) or central centrifugal cicatricial alopecia (CCCA) over a 48-week treatment period. Approximately 30 participants will be enr…
Phase 2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a COPD drug ease rheumatoid arthritis?
Disease control Recruiting nowRheumatoid arthritis is a chronic inflammatory disease that causes joint pain, swelling, and reduced physical function. Although standard disease-modifying antirheumatic drugs are effective for many patients, some individuals continue to have active disease. The purpose of this …
Phase 2 • Sponsor: Horus University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New study aims to ease chronic pain after breast removal
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if the erector spinae block can reduce the incidence of chronic pain compared to the paravertebral block in adult patients undergoing total mastectomy. The study includes patients aged 18 to 80 years scheduled for mastectomy, with or wi…
Sponsor: American University of Beirut Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New heart tool aims to simplify AFib treatment
Disease control Recruiting nowThe main purpose of this study is to investigate the workflow of the clinical use of the pulsed field (PF) ablation system (VARIPULSE catheter and TRUPULSE generator) when used for cardiac ablation with the new VARIPULSE Pro software in participants with persistent atrial fibrill…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
A short lesson before a tracheostomy may calm families' fears
Symptom relief Recruiting nowFamily members of patients undergoing tracheostomy in the intensive care unit frequently experience anxiety, uncertainty, and concerns regarding the patient's care. This randomized controlled trial aims to evaluate the effect of structured education provided to family members of …
Sponsor: Giresun University • Aim: Symptom relief
Last updated Aug 01, 2026 00:00 UTC
-
Sleep apnea study tests pill to boost CPAP use and brain power
Symptom relief Recruiting nowThe study design is a randomized, controlled clinical trial to test the hypothesis that arousal threshold (ArTH) will affect how individuals with obstructive sleep apnea (OSA, Apnea-Hypopnea Index (AHI) of 10/hour of higher) respond to CPAP therapy regarding adherence and cogniti…
Phase 3 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New chemo injection targets tumors directly in early trial
Disease control Recruiting nowThe purpose of Part 1 of this study is to determine a safe, tolerable, and feasible recommended total dose of intratumorally administered JNJ-1761981. The purpose of Part 2 of this study is to identify the optimal volumetric dose of JNJ-1761981 for the treatment of tumor lesions.
Phase 1 • Sponsor: Johnson & Johnson Enterprise Innovation Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Can better sleep stop your migraines? new study investigates
Knowledge-focused Recruiting nowThe MiSleepS study investigates how sleep disturbances and stress are linked to migraine attacks. Participants wear a device called a WHOOP band, which tracks sleep and body signals, and answer brief daily questions via a smartphone app about their sleep, stress levels, and migra…
Sponsor: Susanne Wegener • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Could Twice-Daily insulin shots improve pregnancy outcomes for diabetic moms?
Disease control Recruiting nowThe purpose of this study is to determine if taking insulin glargine twice a day instead of once a day will better manage pregestational diabetes in pregnant patients. Participants in this study will be randomly assigned to one of two groups: a group that takes insulin glargine o…
Phase 4 • Sponsor: Eastern Virginia Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC